Enantioseparation and sensitive analysis of ofloxacin by poly(3,4-dihydroxyphenylalanine) functionalized magnetic nanoparticles-based solid phase extraction in combination with on-line concentration capillary electrophoresis.

Highlights • PolyDOPA-MNPs are prepared and used as adsorbents in MSPE to extract ofloxacin. • The extraction process includes 2 min adsorption and 2 min desorption. • PA-FESI is used to improve the detection sensitivity of ofloxacin enantiomers. • MSPE/PA-FESI CE method is used to determine ofloxacin enantiomers in urine/blood. • The detection limit of each ofloxacin enantiomer is 0.29 ng/mL. Abstract Chiral separation of low concentrations of pharmaceuticals in biofluids is a challenge task. In this study, a method is developed to enantioseparate trace amount of racemic ofloxacin in urine and bovine blood by combining magnetic solid phase extraction (MSPE) and chiral capillary electrophoresis (CE). Poly(3,4-dihydroxyphenylalanine) modified magnetic nanoparticles (polyDOPA-MNPs) are prepared and used as the adsorbents in MSPE to extract ofloxacin. The polyDOPA-MNPs are spherical, about 130 nm in diameter and the polyDOPA shell is about 3 nm. The extraction process of polyDOPA-MNPs for ofloxacin includes 2 min adsorption and 2 min desorption with the assistance of sonication. Under the optimized MSPE conditions (3 mg polyDOPA-MNPs as adsorbents, sample pH 7.0, 75% (v/v) AcOH in methanol as eluent, adsorption time 2 min, desorption time 2 min), the extraction efficiency of ofloxacin is 95%. In chiral CE, pressure-assisted field-enhanced sample injection (PA-FESI) is developed to improve the detection sensitivity of ofloxacin enantiomers. The MSPE/PA-FESI chiral CE method demonstrates a good linearity in the concentration range of 0.01–0.06 μg/mL, with a detection limit as low as 0.29 ng/mL. The feasibility of the method is verified by the successful determination of trace amounts of ofloxacin enantiomers in spiked urine and bovine blood samples. [ABSTRACT FROM AUTHOR]